Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,851 | -9,895 | -6,676 | -4,301 | -14,858 |
| Depreciation Amortization | 4 | 3 | 2 | 1 | 3 |
| Accounts payable and accrued liabilities | 1,543 | -267 | -935 | 373 | -3,634 |
| Other Working Capital | 1,845 | -926 | -1,995 | 996 | -3,694 |
| Other Operating Activity | -1,352 | 326 | 1,019 | -310 | 5,069 |
| Operating Cash Flow | $-13,811 | $-10,759 | $-8,585 | $-3,242 | $-17,113 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | N/A | N/A | N/A | -4 |
| Investing Cash Flow | $-18 | $N/A | $N/A | $N/A | $-4 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,050 | 13,548 | 13,548 | 9,033 | 23,398 |
| Other Financing Activity | 519 | 614 | 706 | 795 | -368 |
| Financing Cash Flow | $14,569 | $14,162 | $14,254 | $9,828 | $23,030 |
| Beginning Cash Position | 6,461 | 6,461 | 6,461 | 6,461 | 549 |
| End Cash Position | 7,201 | 9,864 | 12,130 | 13,048 | 6,461 |
| Net Cash Flow | $740 | $3,403 | $5,669 | $6,586 | $5,913 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,811 | -10,759 | -8,585 | -3,242 | -17,113 |
| Capital Expenditure | -18 | N/A | N/A | N/A | -4 |
| Free Cash Flow | -13,829 | -10,759 | -8,585 | -3,242 | -17,118 |